#105545
#105546
Re: Farmas USA
Menuda paliza le estan dando a REGN
#105547
Re: Farmas USA
#105548
Re: Farmas USA
#105549
Re: Farmas USA
#105550
Re: Farmas USA
Regeneron continues slide, down 6%
Feb. 1, 2018 3:48 PM • SA Editor Douglas W. House
- Regeneron Pharmaceuticals ( REGN -5.5%) continues south. Shares have lost over 11% in a week. The company is scheduled to report Q4 earnings on February 8 before the open.
- Barclay's Geoff Meacham is bearish on the company's prospects (Underweight/$395) citing the saturation of the wet-AMD market which bodes ill for top seller EYLEA (aflibercept).
- Competitor Lucentis (ranibizumab) generated CHF288M in sales in Q4. Regeneron has pre-announced EYLEA Q4 sales at $985M.
- Last quarter, the company forecasted ~10% higher U.S. sales for EYLEA this year or ~$3.66B (2016 sales: $3,323.1M). In his JPM18 presentation, CEO Leonard Schlieifer stated that 2017 sales would be ~$3.7B ( slide #10), in line with the pre-announced $985M for Q4 ($3,711M for the year).
#105551
Re: Farmas USA
Offtopic
APPLE acaba de reportar que tiene 300 BILLONES $ en el banco.
Diossss
#105552
Re: Farmas USA
Jjjjj lo mismo que TESLA ....siempre he dicho en el foro , cual es mi apuesta tecnológica ...entre las dos APPL/TESLA...una sobrada de ideas pero carente de medios y la otra con medios insultantes pero carente de ideas desde que no está el bueno de jobs y abandono el barco el gran John rubistein ...😉
Pd. Mis APPL las compré en 98 y vendí en 125....y mira donde están ahora ...🤔